AU5400000A - Pharmaceutical preparation containing modifications of surfactant protein b (sp-b) and surfactant protein c (sp-c) - Google Patents
Pharmaceutical preparation containing modifications of surfactant protein b (sp-b) and surfactant protein c (sp-c)Info
- Publication number
- AU5400000A AU5400000A AU54000/00A AU5400000A AU5400000A AU 5400000 A AU5400000 A AU 5400000A AU 54000/00 A AU54000/00 A AU 54000/00A AU 5400000 A AU5400000 A AU 5400000A AU 5400000 A AU5400000 A AU 5400000A
- Authority
- AU
- Australia
- Prior art keywords
- surfactant protein
- pharmaceutical preparation
- preparation containing
- containing modifications
- surfactant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 101001086862 Homo sapiens Pulmonary surfactant-associated protein B Proteins 0.000 title 1
- 101000612671 Homo sapiens Pulmonary surfactant-associated protein C Proteins 0.000 title 1
- 102100032617 Pulmonary surfactant-associated protein B Human genes 0.000 title 1
- 102100040971 Pulmonary surfactant-associated protein C Human genes 0.000 title 1
- 238000012986 modification Methods 0.000 title 1
- 230000004048 modification Effects 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0082—Lung surfactant, artificial mucus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Marine Sciences & Fisheries (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99111385 | 1999-06-11 | ||
| EP99111385 | 1999-06-11 | ||
| PCT/EP2000/005032 WO2000076535A1 (en) | 1999-06-11 | 2000-06-02 | Pharmaceutical preparation containing modifications of surfactant protein b (sp-b) and surfactant protein c (sp-c) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU5400000A true AU5400000A (en) | 2001-01-02 |
Family
ID=8238344
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU54000/00A Abandoned AU5400000A (en) | 1999-06-11 | 2000-06-02 | Pharmaceutical preparation containing modifications of surfactant protein b (sp-b) and surfactant protein c (sp-c) |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1189625A1 (en) |
| JP (1) | JP2003501481A (en) |
| AU (1) | AU5400000A (en) |
| CA (1) | CA2372558A1 (en) |
| WO (1) | WO2000076535A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001058423A1 (en) * | 2000-02-11 | 2001-08-16 | Altana Pharma Ag | Novel use of pulmonary surfactant for the prophylaxis and treatment of chronic pulmonary diseases |
| EP1414484A1 (en) * | 2001-08-01 | 2004-05-06 | ALTANA Pharma AG | Combination of selective cox-2 inhibitor and lung surfactant for respiratory syndrome |
| BR0317132A (en) * | 2002-12-09 | 2005-10-25 | Chidren S Hospital Medical Ct | Methods of diagnosis and treatment of interstitial lung disease |
| JP4505416B2 (en) | 2003-12-18 | 2010-07-21 | ユストゥス−リービッヒ−ウニベルズィテート ギーセン | Novel chimeric plasminogen activator and its pharmaceutical use |
| US7582312B2 (en) | 2004-11-15 | 2009-09-01 | Discovery Laboratories, Inc. | Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof |
| EP1997502A1 (en) * | 2007-06-01 | 2008-12-03 | CHIESI FARMACEUTICI S.p.A. | Reconstituted surfactants having improved properties |
| US8399406B2 (en) | 2009-06-05 | 2013-03-19 | Chiesi Farmaceutici S.P.A. | Reconstituted surfactant composition containing analogs of surfactant protein B (SP-B) and surfactant protein C (SP-C) |
| BR112019003673A2 (en) | 2016-08-24 | 2019-05-21 | Chiesi Farmaceutici S.P.A. | pharmaceutical formulation, use of a pharmaceutical formulation and method for preventing increased viscosity during storage of a pharmaceutical formulation |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01501282A (en) * | 1986-12-08 | 1989-05-11 | ホイツトセツト，ジエフリー エイ． | Alveolar hydrophobic surfactant-related protein |
| US6013619A (en) * | 1988-01-06 | 2000-01-11 | The Scripps Research Institute | Pulmonary surfactants and therapeutic uses, including pulmonary lavage |
| DE4418936A1 (en) * | 1994-05-31 | 1996-02-08 | Byk Gulden Lomberg Chem Fab | Polypeptide |
| DE4434629C1 (en) * | 1994-09-28 | 1996-06-27 | Byk Gulden Lomberg Chem Fab | IRDS and ARDS treatment compositions |
| PT877602E (en) * | 1996-01-24 | 2002-07-31 | Byk Gulden Lomberg Chem Fab | PROCESS FOR THE MANUFACTURE OF PULMONARY SURFACTANT COMPOSITIONS IN PO |
-
2000
- 2000-06-02 AU AU54000/00A patent/AU5400000A/en not_active Abandoned
- 2000-06-02 EP EP00938727A patent/EP1189625A1/en not_active Withdrawn
- 2000-06-02 CA CA002372558A patent/CA2372558A1/en not_active Abandoned
- 2000-06-02 WO PCT/EP2000/005032 patent/WO2000076535A1/en not_active Ceased
- 2000-06-02 JP JP2001502868A patent/JP2003501481A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000076535A1 (en) | 2000-12-21 |
| CA2372558A1 (en) | 2000-12-21 |
| EP1189625A1 (en) | 2002-03-27 |
| JP2003501481A (en) | 2003-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2484399A (en) | Controlled release delivery of peptide or protein | |
| AU6516299A (en) | Protein conjugates containing multimers of green fluorescent protein | |
| AU5963900A (en) | Muteins of bilin-binding protein | |
| AUPO066096A0 (en) | Oral delivery of peptides | |
| IL135055A0 (en) | Pharmaceutical compositions containing plasma protein | |
| AU3104295A (en) | Formulations for delivery of osteogenic proteins | |
| AU4300701A (en) | Methods and compositions for administration of therapeutic reagents | |
| PL336889A1 (en) | Preparations of activated protein c | |
| AU3730600A (en) | Compositions preparations and uses of human papillomavirus l1 protein | |
| AU7043298A (en) | Preparation of low-dust stabilisers | |
| AU5134599A (en) | Expression of functional eukaryotic proteins | |
| AU2975899A (en) | Colonic delivery of protein or peptide compositions | |
| AU7352096A (en) | Use of thioethers as antioxidant for peptides and proteins and compositions containing the thioethers | |
| AU5400000A (en) | Pharmaceutical preparation containing modifications of surfactant protein b (sp-b) and surfactant protein c (sp-c) | |
| AU5384699A (en) | Basic peptides and pharmaceutical compositions containing same | |
| AU3471400A (en) | Compositions and methods for controlled delivery of virus vectors | |
| AU7000896A (en) | Novel peptide compounds and medicinal compositions thereof | |
| AU4929497A (en) | Processing of ceramic materials | |
| AU4644299A (en) | Synthetic peptides and pharmaceutical compositions comprising them for diagnosisand treatment of anti-phospholipid syndrome | |
| AU7819898A (en) | Box-dependent myc-interacting protein (bin1) compositions and uses therefor | |
| AU6179600A (en) | Peptides and pharmaceutical compositions comprising same | |
| AU1700801A (en) | Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds | |
| AU2001253336A1 (en) | Method 0f administration of paclitaxel-plasma protein formulation | |
| AU5131699A (en) | Cryogranulation of activated protein c | |
| AU7836798A (en) | Compositions for delivery of biological agents and methods for the preparation thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |